Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?

about

Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes.

P2860

Q36341246-D577C1A9-7E46-4A41-9E87-18FB1FA2B38F

P2860

Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?

Item

http://www.wikidata.org/entity/Q35771271

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Does antihypertensive treatmen ...... nt of diabetic kidney disease?

@ast

Does antihypertensive treatmen ...... nt of diabetic kidney disease?

@en

type

Item

label

Does antihypertensive treatmen ...... nt of diabetic kidney disease?

@ast

Does antihypertensive treatmen ...... nt of diabetic kidney disease?

@en

prefLabel

Does antihypertensive treatmen ...... nt of diabetic kidney disease?

@ast

Does antihypertensive treatmen ...... nt of diabetic kidney disease?

@en

P1476

Does antihypertensive treatmen ...... nt of diabetic kidney disease?

@en

P2093

Akira Babazono

http://www.w3.org/2001/XMLSchema#string

Hiroki Miyazaki

http://www.w3.org/2001/XMLSchema#string

Hiroshi Une

http://www.w3.org/2001/XMLSchema#string

Masayoshi Ichiba

http://www.w3.org/2001/XMLSchema#string

Takuya Imatoh

http://www.w3.org/2001/XMLSchema#string

Toshiki Maeda

http://www.w3.org/2001/XMLSchema#string

P2860

Antihypertensive agents for preventing diabetic kidney disease

Molecular mechanisms of diabetic kidney disease

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Standards of medical care in diabetes--2013

Renal and retinal effects of enalapril and losartan in type 1 diabetes

Preventing microalbuminuria in type 2 diabetes.

P2888

s40360-015-0024-y

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40360-015-0024-Y

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Takumi Nishi

P577

2015-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281713523

http://www.w3.org/2001/XMLSchema#string

P6179

1024116628

http://www.w3.org/2001/XMLSchema#string

P698

26362195

http://www.w3.org/2001/XMLSchema#string

P932

4567802

http://www.w3.org/2001/XMLSchema#string

Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?

about

P2860

P2860

Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932